季线金叉,月线KDJ已掉头向上,大底部持续放量,从历史最低点仅上涨一倍,待利好消息逐步释放,20倍以上目标可待。查看全文
利弗魔尔2021-03-12 02:04
$Invivo治疗控股(NVIV)$ 神经脊髓支架,这个有科技含量啊,异动,估计很快有更大动作,4000万市值,目标3倍。$苹果(AAPL)$ $特斯拉(TSLA)$查看全文
chuminhua2021-03-03 16:37
3月2日,Inovio Pharmaceuticals宣布,其基于DNA的在研HPV免疫疗法VGX-3100在一项后期试验中达到了可评估受试者的主要和次要终点,可作为与人乳头瘤病毒(HPV)相关的高级别鳞状上皮内病变(HSIL)的潜在疗法。首席执行官J.Joseph Kim提出,如果获得批准,VGX-3100有可能 "成为受HPV-16-/18相...查看全文
$Invivo治疗控股(NVIV)$ 8-K Current report, item 5.02 Accession Number: 0001104659-19-062061 Act: 34 Size: 29 KB 网页链接
$Invivo治疗控股(NVIV)$ PRE 14A - Other preliminary proxy statements Filed: 2019-11-08 AccNo: 0001558370-19-010629 Size: 1 MB 网页链接
$Invivo治疗控股(NVIV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001558370-19-010402 Size: 6 MB 网页链接
$Invivo治疗控股(NVIV)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-10-28 AccNo: 0001047469-19-005932 Size: 245 KB 网页链接
$Invivo治疗控股(NVIV)$ 8-K - Current report Filed: 2019-09-27 AccNo: 0001558370-19-008723 Size: 78 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financia...
$Invivo治疗控股(NVIV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001558370-19-008016 Size: 5 MB 网页链接
$Invivo治疗控股(NVIV)$ 8-K - Current report Filed: 2019-07-19 AccNo: 0001558370-19-006165 Size: 36 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Invivo治疗控股(NVIV)$ 8-K - Current report Filed: 2019-07-12 AccNo: 0001558370-19-006077 Size: 47 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Invivo治疗控股(NVIV)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-07-12 AccNo: 0001558370-19-006079 Size: 89 KB 网页链接
$Invivo治疗控股(NVIV)$ 8-K - Current report Filed: 2019-07-05 AccNo: 0001558370-19-006018 Size: 32 KBItem 8.01: Other Events 网页链接